Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Charles Schwab Bank »

Orexigen Therapeutics shares owned by Charles Schwab Bank

Quarter-by-quarter ownership of Orexigen Therapeutics shares owned by Charles Schwab Bank from 13F filings

Historical chart of Charles Schwab Bank investment in Orexigen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orexigen Therapeutics held by Charles Schwab Bank consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Quarterly reported holdings in Orexigen Therapeutics by Charles Schwab Bank

Quarter filed	Position value	Share count	Share price at filing
2013-03-31	$181k	29k	6.24

More positions owned by Charles Schwab Bank

View all positions for Charles Schwab Bank

Top funds holding Orexigen Therapeutics

Huntington National Bank

View all funds holding Orexigen Therapeutics

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z